Standout Papers
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. (1999)
Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
2005
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
2010 Standout
PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
2018 StandoutScienceNobel
Origins and evolution of the Western diet: health implications for the 21st century1,2
2005 Standout
Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation
2007
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
2007 Standout
Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators
2006
Clinical Overview of Omacor: A Concentrated Formulation of Omega-3 Polyunsaturated Fatty Acids
2006
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
2000 Standout
Mercury, Fish Oils, and the Risk of Myocardial Infarction
2002
An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia
2001
Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease
2011
A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution
2004
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation
2011
Fish Consumption and Stroke Risk in Elderly Individuals
2005
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
2005 Standout
Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis
2015
Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised‐controlled trial
2005
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure
2005
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry
2004
long-term effect of combined vitamins e and c on coronary and peripheral endothelial function
2004
Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2010 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women
2001 Standout
Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction
2001
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
2008
Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease
2000
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
1998 Standout
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease
2004
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
2008 Standout
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
2010
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
2009 StandoutNature
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
2002
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
2001
Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial
2008
Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study
2014
Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study
1996
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Long-chainn−3 PUFA: plantv. marine sources
2006
Nonresolving Inflammation
2010 Standout
The Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto miocardio (GISSI)-Prevenzione trial on fish oil and vitamin E supplementation in myocardial infarction survivors
2000
Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults
2008
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
2002
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study
2004
Vitamin E supplementation and cataract
2004
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Vitamins E and C in the Prevention of Cardiovascular Disease in Men
2008
The development of allergic inflammation
2008 StandoutNature
Fish Intake, Contaminants, and Human Health
2006 Standout
Resolvin E2: Identification and Anti-Inflammatory Actions: Pivotal Role of Human 5-Lipoxygenase in Resolvin E Series Biosynthesis
2006
The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats
2011
Comparison of a vitamin E-rich diet and supplemental vitamin E on measures of vitamin E status and lipoprotein profile
2001
Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man
2007
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus
2003
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways
2001
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
2011
Vitamin Supplement Use in a Low-Risk Population of US Male Physicians and Subsequent Cardiovascular Mortality
2002
Women's Angiographic Vitamin and Estrogen trial:
2002
Is Antioxidant and n–3 Supplementation Able to Improve Functional Status in Poststroke Patients? Results from the Nutristroke Trial
2009
Resolution of inflammation: the beginning programs the end
2005 Standout
Effects of Vitamin E on Lipid Peroxidation in Healthy Persons
2001
Management of acute myocardial infarction in patients presenting with ST-segment elevation
2003
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart
2001
Vitamin E Supplementation and Plasma 8‐Isoprostane and Adiponectin in Overweight Subjects
2007
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
2006
Origin and physiological roles of inflammation
2008 StandoutNature
Prolonged, low dose α-tocopherol therapy counteracts intercellular cell adhesion molecule-1 activation
2002
Vitamins E and C in the Prevention of Prostate and Total Cancer in Men
2008
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
2001
Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment
2004
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review
2006
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Supplementation With Vitamins C and E Improves Arterial Stiffness and Endothelial Function in Essential Hypertensive Patients
2007
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Vitamin C pharmacokinetics of plain and slow release formulations in smokers
2004
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Dietary Fish and n-3 Fatty Acid Intake and Cardiac Electrocardiographic Parameters in Humans
2006
Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study
2006
n−3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review
2006
Effects of n–3 fatty acids from fish on premature ventricular complexes and heart rate in humans
2005
Supplementation with mixed tocopherols increases serum and blood cell γ-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes
2006
A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women
2007
A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins
2017
Heart failure after myocardial infarction: a review
2002
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials
2001
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications
2008
Cardiovascular benefits of omega-3 fatty acids
2006
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
The relationship between dose of vitamin E and suppression of oxidative stress in humans
2007
Effects of oral vitamin C on monocyte: endothelial cell adhesion in healthy subjects
2002
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor
2007
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
2018
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n‐3 polyunsaturated fatty acids
2005
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context
2003
The Women's Antioxidant Cardiovascular Study: Design and Baseline Characteristics of Participants
2004
Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans
2005
Effect of Fish Oil on Heart Rate in Humans
2005
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
n−3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study
2003
Fish Consumption Is Associated With Lower Heart Rates
2003
Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms
2006
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
2007
The resolution of inflammation: the devil in the flask and in the details
2011
The Effect of Vitamin E on Endothelial Function of Micro- and Macrocirculation and Left Ventricular Function in Type 1 and Type 2 Diabetic Patients
2005
The Chemical Form of Mercury in Fish
2003 StandoutScience
Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing
2000
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Cardiac Benefits of Fish Consumption May Depend on the Type of Fish Meal Consumed
2003
Effects of Vitamin E Supplementation on F2-Isoprostane and Thromboxane Biosynthesis in Healthy Cigarette Smokers
2000
Fish Intake and Risk of Incident Atrial Fibrillation
2004
Clinical Prevention of Sudden Cardiac Death by n-3 Polyunsaturated Fatty Acids and Mechanism of Prevention of Arrhythmias by n-3 Fish Oils
2003
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Intake of Fish and n3 Fatty Acids and Risk of Coronary Heart Disease Among Japanese
2006
12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient Mice
2001
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials
1997
Disease Tolerance as a Defense Strategy
2012 StandoutScience
Molecular and structural antioxidant defenses against oxidative stress in animals
2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Efficacy of n‐3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI‐prevenzione trial
2001
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
2004 Standout
Effect of dietary supplementation with ω-3 fatty acids on progression of atherosclerosis in carotid arteries
2002
Epidemiology and Genetics of Sudden Cardiac Death
2012
Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries
2004
Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models
2001
Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution
2008
Ascorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes
2002
Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?
2002
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
2008
Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes
2002
Omega 3 Fatty Acids and Cardiovascular Outcomes
2012
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
Vitamin E Reduces Cardiovascular Disease in Individuals with Diabetes Mellitus and the Haptoglobin 2-2 Genotype
2010
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype
2007
The results of the GISSI-Prevenzione trial in the general framework of secondary prevention
2000
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
2018
Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men
2005
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Effects of Ramipril and Vitamin E on Atherosclerosis
2001
Anti-Inflammatory and Proresolving Lipid Mediators
2008
GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
1994
Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways
2006
Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake
2005
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
2012
n−3 polyunsaturated fatty acids and coronary thrombosis
2001
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
2002 Standout
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction
1995
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
2005
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
AHA Dietary Guidelines
2000
Rationale and design of REDUCE‐IT : Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
2017
Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis
2002
Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans
2004
Resolvins
2002
Works of E. Geraci being referenced
The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial
1996
Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base.
1993
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
1999 Standout
[A chart of post-acute myocardial infarct risk: results in the first 18 months of the GSSI follow-up study].
1998
Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
2000